Manufacturing

Articles

Baxter will provide commercial-scale manufacturing services at its Halle/Westfalen, Germany facility to prepare Novavax’s COVID-19 vaccine candidate for distribution in the United Kingdom and European markets.

Baxter and Novavax Enter into COVID-19 Vaccine Sterile Manufacturing Agreement

Bayer will support the development and supply of CureVac’s COVID-19 vaccine candidate, CVnCoV.

Bayer and CureVac to Collaborate on COVID-19 Vaccine Candidate

The company plans to deliver initial doses by mid-2021, and Australia will have the option to purchase up to 10 million additional doses through the agreement. 

Novavax Enters into Agreement with the Commonwealth of Australia for 51 Million Doses of its COVID-19 Vaccine

Intravacc and Cristal Therapeutics have entered into a strategic collaboration for the development of novel vaccine programs against human diseases.

Intravacc, Cristal Therapeutics Collaborate on Novel Vaccine Platforms

Amid pressure to get more vaccines administered faster, FDA pushes back against changes in dosing regimens.

FDA: Stick with Approved EUAs for COVID-19 Vaccines

Part of Operation Warp Speed, the trial will enroll 30,000 people ages 18 to 64 and 65 and older at 115 sites.

Phase III Trial of Novavax COVID-19 Trial Open for Enrollment in the US and Mexico

The companies have entered into an agreement to support the formulation and fill/finish of Moderna’s COVID-19 vaccine supply outside of the United States. 

Moderna and Recipharm Announce COVID-19 Vaccine Supply Agreement 

After a hectic 2020, biopharma looks to deliver on COVID-19 vaccines and move other promising therapies forward.

Biopharma Gets Back to “New Normal” Business

Jennifer Markarian is manufacturing editor of BioPharm International.

Packaging and transporting large quantities of COVID-19 vaccines pose challenges for the cold chain.

Accelerating Technology Adoption to Track the Cold Chain

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

Outsourcing increases as the industry balances development and manufacturing of both COVID-19 treatments and non-pandemic-related medicines.

Vaccine Development and Manufacturing